(MedPage Today) — Surveillance data on foodborne disease outbreaks in 2007 revealed that norovirus and Salmonella contamination were the leading causes, with poultry, beef, and leafy greens the most common foods involved, the CDC reported.
No Comments »
Filed under: General Health News
(MedPage Today) — Many of the metrics currently used to assess quality of hospital care fail to provide true and valuable accountability, according to leaders of a key organization that helped develop them.
No Comments »
Filed under: General Health News
(MedPage Today) — Alcohol companies have substantially cut down on the amount of magazine ads aimed at underage individuals, but young people are still being overexposed to such ads — especially those for beer, according to a new report.
No Comments »
Filed under: General Health News
(MedPage Today) — Using a shorter informed consent form did not hamper — or improve — research participants’ understanding of a study, but may ultimately save time in writing and reviewing important information, researchers found.
No Comments »
Filed under: General Health News
(MedPage Today) — SILVER SPRING, Md. — An FDA advisory committee voted 13-0 Wednesday that ezogabine (Potiga) is an effective adjunctive treatment for epilepsy patients with partial-onset seizures.
No Comments »
Filed under: General Health News
(MedPage Today) — The antiepileptic drug lamotrigine (Lamictal), also approved for maintenance therapy in bipolar disorder, can cause aseptic meningitis, the FDA warned.
No Comments »
Filed under: Pharmacy News
LifeCycle Pharma A/S today announced receipt of agreement with the U.S. Food and Drug Administration on a Special Protocol Assessment of its pivotal Phase 3 study, Study 3002, for LCP-Tacro in patients, who have just received a kidney transplant.
No Comments »
Filed under: Pharmacy News
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today reported financial and operating results for the second quarter ended June 30, 2010.
No Comments »
Filed under: Pharmacy News
BioMimetic Therapeutics, Inc. today announced that it has received orphan drug designation from the Food and Drug Administration for its protein therapeutic, recombinant human platelet derived growth factor, to be used in conjunction with autograft and/or commercially available osteochondral allograft for the treatment of osteochondritis dissecans of the knee, elbow or ankle.
No Comments »
Filed under: Pharmacy News
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has achieved its enrollment target for TIVO-1, its global Phase 3 clinical trial for its oral, triple VEGF receptor inhibitor, tivozanib, in patients with advanced renal cell carcinoma. In February of this year, AVEO initiated enrollment in [...]
No Comments »
Filed under: Pharmacy News
